MAPT and Alzheimer disease: Deposition of amyloid-β plaques (Aβ), hyperphosphorylation of tau, and initiation of several neurometabolic responses in the brain, followed by the loss of neuronal and synaptic functions, and also the impairment of learning and memory functions, are the central neuropathological characteristics of AD.